NWZ, location Alkmaar
Alkmaar, Noord-Holland, Netherlands
Hospital in Alkmaar
Wilhelminalaan 12, 1815 JD Alkmaar
About NWZ, location Alkmaar
"Wij zijn Noordwest Ziekenhuisgroep. Een ziekenhuisgroep waarin iedereen samenwerkt aan het zelfde doel: de beste zorg voor onze patiënt. Inwoners van Noordwest-Nederland kunnen bij ons terecht voor uitstekende basiszorg en complexe specialistische zorg. Noordwest Ziekenhuisgroep is ontstaan uit de fusie van Medisch Centrum Alkmaar en het Gemini Ziekenhuis. Al vele jaren bieden beide ziekenhuizen zorg aan de inwoners in Noordwest-Nederland. Met onze nieuwe naam verbinden we ons duidelijk aan deze regio. Onze ambitie is een toonaangevende ziekenhuisgroep te zijn, met een hoge medische standaard én mensgerichte zorg."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Shire
3
Clinical Trials at NWZ, location Alkmaar
During the past decade, NWZ, location Alkmaar conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis
2018-02-09
2020-10-23
Terminated
380
A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
2018-02-27
2023-12-31
Active, not recruiting
557
An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis
2018-04-04
2021-07-01
Completed
366
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at NWZ, location Alkmaar
According to Clinical.Site data, the most researched conditions in "NWZ, location Alkmaar" are
"Ulcerative Colitis" (3 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "NWZ, location Alkmaar" in a lesser frequency.
Clinical Trials Intervention Types at NWZ, location Alkmaar
Most popular intervention types in "NWZ, location Alkmaar" are "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Ontamalimab" (2 trials), "Placebo" (2 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at NWZ, location Alkmaar
The vast majority of trials in "NWZ, location Alkmaar" are
3 trials for "All" genders.
Clinical Trials Status at NWZ, location Alkmaar
Currently, there are NaN active trials in "NWZ, location Alkmaar".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in NWZ, location Alkmaar,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in NWZ, location Alkmaar, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".